What is Epocrates?
Epocrates is a leading developer of medical applications designed for U.S. physicians. Its platform offers critical clinical intelligence, essential practice management tools, and facilitates health industry engagement directly at the point of care. As an integral part of athenahealth, Epocrates leverages its technology to enhance physician workflow, improve patient outcomes, and streamline healthcare operations. The company's focus on mobile accessibility and data-driven insights positions it as a key player in digital health innovation.
How much funding has Epocrates raised?
Epocrates has raised a total of $138M across 4 funding rounds:
Series A
$10.8M
Series B
$35M
Series C
$6.4M
Stock Offering
$85.8M
Series A (1999): $10.8M, investors not publicly disclosed
Series B (2000): $35M led by InterWest Partners, Bay City Capital, Three Arch Partners, Draper Fisher Jurvetson (DFJ), and Sprout Group
Series C (2002): $6.4M supported by Bay City Capital, Sprout Group, Three Arch Partners, Draper Fisher Jurvetson (DFJ), and InterWest Partners
Stock Issuance/Offering (2011): $85.8M, investors not publicly disclosed
Key Investors in Epocrates
Bay City Capital
Bay City Capital is a venture capital firm specializing in life sciences investments, known for backing companies with significant milestones like FDA approvals and therapeutic advancements.
Three Arch Partners
Three Arch Partners focuses on medical devices and healthcare services, actively creating and funding new healthcare companies with a strong emphasis on clinical and business resources.
Draper Fisher Jurvetson (DFJ)
Draper Fisher Jurvetson is a global venture capital firm dedicated to supporting extraordinary entrepreneurs, with a broad portfolio across various technology sectors including healthcare.
What's next for Epocrates?
The substantial enterprise-level funding and recent strategic investment indicate Epocrates is poised for further expansion and innovation. This capital infusion will likely fuel the development of new features, enhance its existing suite of medical applications, and potentially broaden its market reach. With a strong foundation in providing clinical decision support and practice management tools, Epocrates is well-positioned to capitalize on the increasing demand for digital health solutions that improve efficiency and patient care within the U.S. physician community. Future growth may involve deeper integration with electronic health records and expanded data analytics capabilities.
See full Epocrates company page
